State Policies for Prescription Drug Monitoring Programs and Adverse Opioid-related Hospital Events.

ABSTRACT:

Background

State policies to optimize prescriber use of Prescription Drug Monitoring Programs (PDMPs) have proliferated in recent years. Prominent policies include comprehensive mandates for prescriber use of PDMP, laws allowing delegation of PDMP access to office staff, and interstate PDMP data sharing. Evidence is limited regarding the effects of these policies on adverse opioid-related hospital events.

Objective

The objective of this study was to assess the effects of 3 PDMP policies on adverse opioid-related hospital events among patients with prescription opioid use.

Research design

We examined 2011-2015 data from a large national commercial insurance database of privately insured and Medicare Advantage patients from 28 states with fully operating PDMPs by the en

SUBMITTER: Wen K 

PROVIDER: S-EPMC7985821 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature